British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011

被引：142

作者：

Asboe, D. ^{[1
]}

Aitken, C. ^{[1
]}

Boffito, M. ^{[1
]}

Booth, C. ^{[1
]}

Cane, P. ^{[1
]}

Fakoya, A. ^{[1
]}

Geretti, A. M. ^{[1
]}

Kelleher, P. ^{[1
]}

Mackie, N. ^{[1
]}

Muir, D. ^{[1
]}

Murphy, G. ^{[1
]}

Orkin, C. ^{[1
]}

Post, F. ^{[1
]}

Rooney, G. ^{[1
]}

Sabin, C. ^{[1
]}

Sherr, L. ^{[1
]}

Smit, E. ^{[1
]}

Tong, W. ^{[1
]}

Ustianowski, A. ^{[1
]}

Valappil, M. ^{[1
]}

Walsh, J. ^{[1
]}

Williams, M. ^{[1
]}

Yirrell, D. ^{[1
]}

机构：

[1] Mediscript Ltd, British HIV Assoc BHIVA, BHIVA Secretariat, London, England

来源：

HIV MEDICINE | 2012年 / 13卷 / 01期

关键词：

antiretroviral-experienced; antiretroviral-naive; assessment; HIV positive; monitoring; HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL-DRUG-RESISTANCE; HERPES-SIMPLEX-VIRUS; TREATMENT-EXPERIENCED PATIENTS; REVERSE-TRANSCRIPTASE INHIBITORS; CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; PLASMA VIRAL LOAD; ANAL INTRAEPITHELIAL NEOPLASIA; TROPICAL INFECTIOUS-DISEASES;

D O I：

10.1111/j.1468-1293.2011.00971.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：1 / 44

页数：44

共 50 条

[41] Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals
David J. Back
Andrew Owen
Saye H. Khoo
Clinical Pharmacokinetics, 2006, 45 : 213 - 214
[42] Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals
Barcelo, Catalina
Gaspar, Frederic
Aouri, Manel
Panchaud, Alice
Rotger, Margalida
Guidi, Monia
Cavassini, Matthias
Buclin, Thierry
Decosterd, Laurent A.
Csajka, Chantal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (07) : 1933 - 1942
[43] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals
Kappelhoff, BS
Huitema, ADR
Yalvaç, Z
Prins, JM
Mulder, JW
Meenhorst, PL
Beijnen, JH
CLINICAL PHARMACOKINETICS, 2005, 44 (08) : 849 - 861
[44] Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals
Bregt S. Kappelhoff
Alwin D. R. Huitema
Zeynep Yalvaç
Jan M. Prins
Jan W. Mulder
Pieter L. Meenhorst
Jos H. Beijnen
Clinical Pharmacokinetics, 2005, 44 : 849 - 861
[45] Drug interaction of fluvoxamine and fluoxetine with nevirapine in HIV-1-infected individuals
de Maat, MM
Huitema, ADR
Mulder, JW
Meenhorst, PL
van Gorp, ECM
Mairuhu, ATA
Beijnen, JH
CLINICAL DRUG INVESTIGATION, 2003, 23 (10) : 629 - 637
[46] Cytokine Expression During Syphilis Infection in HIV-1-Infected Individuals
Knudsen, Andreas
Benfield, Thomas
Kofoed, Kristian
SEXUALLY TRANSMITTED DISEASES, 2009, 36 (05) : 300 - 304
[47] Underestimated Amoebic Appendicitis among HIV-1-Infected Individuals in Japan
Kobayashi, Taiichiro
Watanabe, Koji
Yano, Hideaki
Murata, Yukinori
Igari, Toru
Nakada-Tsukui, Kumiko
Yagita, Kenji
Nozaki, Tomoyoshi
Kaku, Mitsuo
Tsukada, Kunihisa
Gatanaga, Hiroyuki
Kikuchi, Yoshimi
Oka, Shinichi
JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (01) : 313 - 320
[48] SUBCORTICAL PROFILE OF MEMORY COMPROMISE AMONG HIV-1-INFECTED INDIVIDUALS
Schiller, Allen
Foley, Jessica
Burns, William
Sellers, A. L.
Golden, Charles
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2009, 119 (10) : 1779 - 1803
[49] Plasma and salivary IgA and IgA antibodies in HIV-1-infected individuals
Wu, XL
Jackson, S
FASEB JOURNAL, 2000, 14 (06): : A942 - A942
[50] Attenuated signaling associated with immune activation in HIV-1-infected individuals
Leng, QB
Borkow, G
Bentwich, Z
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 298 (04) : 464 - 467

← 1 2 3 4 5 →